Induction of chondrogenic phenotype in synovium-derived progenitor cells by intermittent hydrostatic pressure  by Sakao, K. et al.
Osteoarthritis and Cartilage (2008) 16, 805e814
ª 2007 Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.
doi:10.1016/j.joca.2007.10.021
International
Cartilage
Repair
SocietyInduction of chondrogenic phenotype in synovium-derived progenitor
cells by intermittent hydrostatic pressure
K. Sakao M.D., K. A. Takahashi M.D., Ph.D.*, Y. Arai M.D., Ph.D., A. Inoue M.D., Ph.D.,
H. Tonomura M.D., Ph.D., M. Saito M.D., T. Yamamoto M.D., Ph.D., N. Kanamura M.D., Ph.D.,
J. Imanishi M.D., Ph.D., O. Mazda M.D., Ph.D. and T. Kubo M.D., Ph.D.
Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan
Summary
Objective: The aim of this study was to investigate the effect of intermittent hydrostatic pressure (IHP) on chondrogenic differentiation of
synovium-derived progenitor cells (SPCs).
Methods: SPCs, bone marrow-derived progenitor cells and skin ﬁbroblasts from rabbits were subjected to IHP ranging from 1.0 to 5.0 MPa.
The mRNA expression of proteoglycan core protein (PG), collagen type II and SOX-9 was examined using real-time reverse transcriptase-
polymerase chain reaction (RT-PCR). The production of SOX-9 protein and glycosaminoglycan (GAG) by SPCs was analyzed by Western
blot and the dimethylmethylene blue assay. In addition, mitogen-activated protein (MAP) kinase inhibitors for c-Jun N-terminal kinase
(JNK), extracellular signal-regulated kinase (ERK), and the p38 pathway were used to identify the signal transduction pathways.
Results: Real-time RT-PCR showed that mRNA expression of PG, collagen type II and SOX-9 was signiﬁcantly enhanced only in SPCs
receiving 5.0 MPa of IHP. The production of SOX-9 protein and GAG by SPCs was also increased by exposure to 5.0 MPa of IHP. These
up-regulated expressions were suppressed by pretreatment with an inhibitor of JNK, but not with inhibitors of ERK or p38.
Conclusion: Our results demonstrated that the exposure of SPCs to 5.0 MPa of IHP could facilitate induction of the chondrogenic phenotype
by the MAP kinase/JNK pathway. This ﬁnding suggests the potential for IHP utilization in regenerative treatments for cartilage injuries or
osteoarthritis.
ª 2007 Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.
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Articular cartilage, which is a hyaline cartilage, cannot easily
regenerate when damaged by trauma or osteoarthritis (OA).
Autologous osteochondral transplantation and autologous
chondrocyte implantation have been performed for limited
areas of cartilage damage with favorable outcomes1. How-
ever, these techniques are currently not useful for extensive
cartilage damage or the cartilage degeneration of OA.
When OA causes severe cartilage destruction, surgical pro-
cedures, such as artiﬁcial joint replacement, can restore
joint functions but are highly invasive and expensive. In
addition, these artiﬁcial replacements have limited life-
times2. New treatments for extensive cartilage damage or
degeneration are thus needed.
Because of recent advances in tissue engineering, carti-
lage repair using various types of cells has been performed.
Important characteristics of cells used for cell therapy
include the ability to proliferate at a high rate and the poten-
tial for multi-differentiation. As a cell source for regenerating*Address correspondence and reprint requests to: Dr Kenji A.
Takahashi, Kyoto Prefectural University of Medicine, Department of
Orthopaedics, Graduate School of Medical Science, Kawaramachi-
Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan. Tel: 81-75-251-
5549; Fax: 81-75-251-5841; E-mail: t-keji@mbox.kyoto-inet.or.jp
Received 23 May 2007; revision accepted 29 October 2007.
805cartilage, undifferentiated progenitor cells3, which have the
potential for self-renewal and have the capability to differen-
tiate into chondrocytes, are being scrutinized. Proteoglycan
core protein (PG) and collagen type II genes are coordi-
nately regulated during the course of chondrogenic differen-
tiation4. The expressions of these genes are deﬁned as
markers of chondrogenesis in many studies. Several recent
reports have shown that progenitor cells derived from bone
marrow5, periosteum6, adipose tissue7, skeletal muscle8
and synovium9 have chondrogenic differentiation potential
in vitro. Cartilage regeneration using bone marrow-derived
progenitor cells (BPCs) has been investigated in animal
models of OA10 and some clinical studies have been
conducted11. At present, studies are being conducted to
regenerate cartilage from BPCs using growth factors and
gene transfer techniques12,13; however, the complete repair
of hyaline cartilage is not yet achievable. In addition, as
BPCs divide further, the lineages of cells into which they
can differentiate decrease and there are limits on cell divi-
sion and proliferation. Therefore, it is highly desirable to
improve the methods for stimulating differentiation of
BPCs into articular chondrocytes.
Synovial chondromatosis, or chondroplasis of the synovial
tissue, suggests that synovial tissue candifferentiate into car-
tilage14,15. Interestingly, synovium-derived progenitor cells
(SPCs) are involved in the repair process of damaged carti-
lage16. Furthermore, in vitro studies have shown that SPCs
are capable of differentiating into chondrocytes9. Recent
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bone marrow, periosteum, adipose tissue, skeletal muscle
or synovium, chondrocyte differentiation and proliferation
are most active in SPCs17,18. Fibroblasts derived from the
skin also have a high cell proliferation ability and chondro-
genic differentiation potential19. Skin ﬁbroblasts (SFs) are
easily harvested with minimal invasion20. Therefore, BPCs,
SPCs and SFs are all promising cell sources for cell therapy
for cartilage repair.
In synovial joints, the mechanical stress generated by
joint movements and loading plays an important role in
cartilage regeneration21. A study using an animal model
of cartilage damage suggests that cartilage damage in
non-weight-bearing areas is insufﬁciently repaired, while
that in weight-bearing areas is repaired well22. The mechan-
ical environment is therefore likely to have a marked impact
on differentiation of progenitor cells involved with the carti-
lage repair process in vivo. Articular cartilage is always
subjected to a variety of mechanical stresses, which include
tensile force, shearing force, compressive force and hydro-
static pressure23. Of the various mechanical stresses
applied to the articular cartilage, hydrostatic pressure
strongly affects the extracellular matrix (ECM) synthesis
and cartilage regeneration24e28. It has been hypothesized
that mechanical stress is transferred from the ECM to nuclei
via cytoskeleton, which is connected with integrin, non-
integrin ECM receptors, cellecell adhesion molecules or
ion channels on the cellular surface29e32. These biome-
chanical signals were reported to be mediated by the
mitogen-activated protein (MAP) kinase, rho kinase or tyro-
sine kinase signal transduction pathways33e35. However,
insufﬁcient studies have been conducted on the inductive
mechanism of cartilage differentiation by mechanical stress
applied to progenitor cells.
To develop a new cartilage repair technique based on
mechanical stress applications, we focused on intermittent
hydrostatic pressure (IHP), which has a major effect on car-
tilage metabolism. We then ascertained whether IHP could
induce cartilage differentiation in SPCs, BPCs and SFs.
Materials and methods
This study was conducted according to the guidelines for animal research
at Kyoto Prefectural University of Medicine.SPCsA total of 20 male Japanese white rabbits weighing 2 kg (7e9-week-old)
(Oriental BioService, Kyoto, Japan) were used to assess the reproducibility
of repeated experiments using SPCs. SPCs were isolated as described in
previous studies9,17,36. Brieﬂy, the rabbits were euthanized by administering
a lethal dose of sodium pentobarbital (Nembutal; Abbott, North Chicago, IL,
USA). Synovial tissues were aseptically collected from bilateral knee joints
after careful dissection of the subsynovial tissue to separate the thin synovial
intima. The synovial specimens were cut into small pieces and incubated
with 0.2% collagenase (collagenase S-1; Nitta Gelatin Inc., Osaka, Japan)
for 2 h. The remaining undigested tissue was removed by ﬁltration of the
digest through a 20-mm pore membrane. The cells were plated in Dulbecco’s
modiﬁed Eagle’s medium (DMEM) containing 4.5 g/l glucose, 0.584 g/l
L-glutamine and 0.11 g/l sodium pyruvate (Nacalai Tesque, Inc., Kyoto,
Japan) that was supplemented with 10% fetal bovine serum (FBS) (Trace Sci-
entiﬁc Ltd., Melbourne, Australia), 100 units/ml penicillin and 100 mg/ml strep-
tomycin (Gibco BRL, Gaithersburg, MD, USA) in a 100-mm dish at a density
of 6 103 cells/cm2. Non-adherent cells were removed, when the medium
was changed. Consequently, the population consisted almost entirely of the
ﬁbroblast-like cells during subculture for 2 weeks. The SPCs were contained
within the ﬁbroblast-like cells that adhered to the culture plate17.BPCsBPCs were isolated as described in a previous study37. Brieﬂy, tibias and
femurs were harvested from 10 euthanized rabbits. A 10-ml syringecontaining 3 ml of heparin (3000 units in total) (Ajinomoto Pharma, Tokyo,
Japan) with a 16-gage needle was used to aspirate the bone marrow from
the tibial and femoral shafts. The marrow was placed in a 50-ml tube with
DMEM and centrifuged at 600g for 10 min. After removing the supernatant,
the cells were resuspended in DMEM in a 100-mm dish at a density of
6 103 cells/cm2. Non-adherent cells were removed when the medium
was changed.SFsSFs were isolated as described in a previous study20. Brieﬂy, skin was
harvested from 10 euthanized rabbits, and the dermis was detached from
the epidermis, subcutaneous tissue and vascular structures. The dermis
was minced into small pieces and 10 fragments were placed on the bottom
of a 100-mm dish in DMEM, such that each fragment was positioned apart
from the others. The medium was changed 24 h later, and non-adherent
materials were discarded.ARTICULAR CHONDROCYTES (ACs)ACs were isolated as previously described38. Brieﬂy, the cartilage tissues
were aseptically collected from the full thickness cartilage of bilateral knee,
hip, and shoulder joints of eight euthanized rabbits. The specimens were
minced into small pieces and treated with 0.015% trypsin (Gibco BRL) for
1 h, followed by digestion with 0.025% collagenase for 8 h. The remaining
undigested tissues were removed by ﬁltration of the digest through
a 20-mm pore membrane, and the cells were plated in DMEM in a 100-mm
dish at a density of 6 103 cells/cm2. Upon conﬂuency, passage-0 cells
were treated with trypsin/ethylenediamine-tetraacetic acid (EDTA) (Nacalai
Tesque) and resuspended in DMEM until used for experiments (passage-
1). We conﬁrmed that the chondrogenic phenotype was maintained in
passage-1 cells (data not shown).CELL CULTURE IN MONOLAYERSPCs, BPCs, or SFs were cultured at 37C in 5% CO2/95% humidiﬁed air
(standard conditions) in DMEM in a 100-mm dish at a density of
6 103 cells/cm2 for 2 weeks. The medium was changed every 4 days. After
the 2 weeks of culture in monolayer, cells from the second passage were
treated with EDTA (Nacalai Tesque) and resuspended in DMEM in
a 60-mm dish at a density of 5 104 cells/cm2. After 24 h of cultivation under
the standard conditions, the cells were seeded in serum-free DMEM for 2 h
until the pressure loading experiments were performed.THREE-DIMENSIONAL CULTURE OF SPCs IN ALGINATE BEADSAfter 2 weeks in monolayer culture, SPCs from the second passage were
suspended in physiological saline containing 1.2% alginate (SigmaeAldrich,
St. Louis, MO, USA) at a density of 4 106 cells/ml. The alginate cell sus-
pension was dropped into 102 mM calcium chloride solution using a syringe
with a 22-gage needle to form alginate beads39. These beads were cultured
in serum-free DMEM for 2 h until the pressure loading experiments were
performed.MAP KINASE INHIBITIONIndividual MAP kinase pathways were blocked as previously descri-
bed40e44. SPCs were seeded into a 60-mm dish in DMEM at a density of
5 104 cells/cm2 in monolayer. After 24 h of cultivation under the standard
conditions, the c-Jun N-terminal kinase (JNK) pathway inhibitor, SP600125
(speciﬁc for JNK-1, -2 and -3) (Calbiochem, San Diego, CA, USA), the extra-
cellular signal-regulated kinase (ERK) 1/2 pathway inhibitor, U0126 (speciﬁc
for anti-phospho-MAP kinase kinase (MEK) 1/2) (Promega, Madison, WI,
USA), or the p38 MAP kinase pathway inhibitor, SB203580 (speciﬁc for
p38a, p38b and p38b2) (Promega), was added to each dish at a concentra-
tion of 10 mM in serum-free DMEM and the cells were cultured for 2 h. For
each inhibitor, the gene expression of proteoglycan core protein (PG), colla-
gen type II and SOX-9, was analyzed using one-way analysis of variance
(ANOVA) to investigate the differences between the untreated group and
pretreated groups, after which a comparative analysis using these inhibitors
was performed.IHP APPARATUSA specially designed system was devised to apply IHP to the cells (Hikari
Koatsu, Hiroshima, Japan) (Fig. 1). The 60-mm petri dishes were placed in
an impermeable, deformable Teﬂon pouch, which was then ﬁlled with
thermometer
incubator
water
out
pressurization vessel
petri dish and cells
culture medium
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in
cylinder valve
pump
controlled by computer
thermostat
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Fig. 1. Diagram of a special IHP apparatus. This apparatus was
devised to apply IHP to cells. The pump and cylinder valve were
controlled by a computer such that the pouch was subjected to
hydrostatic pressure being applied using a sinusoidal waveform.
Hydrostatic pressure was transmitted through the gas-free culture
medium and the temperature was controlled by using a thermostat.
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pressurization vessel was ﬁlled with water to uniformly transmit pressure to
the cells through the serum-free culture medium in the packed Teﬂon pouch
in a gas-free environment. We conﬁrmed that the pH in culture medium did
not change during exposure to IHP for 1 h (data not shown). The pump and
cylinder valve were controlled by a computer and the pouch was subjected to
hydrostatic pressure at three levels [0 MPa (control), 1.0 MPa or 5.0 MPa]
using a sinusoidal waveform protocol simulating walking: frequency;
0.5 Hz, magnitude; a minimum applied pressure of 0 MPa and a maximum
pressure of 5.0 MPa. The temperature was maintained at 37C by using
a computer-controlled thermostat placed in the pressure vessel.APPLICATION OF IHPThe cells were exposed to IHP at 0 MPa (control), 1.0 MPa, or 5.0 MPa for
1 h. When the exposure to IHP was terminated, the dishes were removed
from the pressurization apparatus and maintained at atmospheric pressure
under the standard conditions. Cells placed in the same apparatus and
treated with 0 MPa of IHP were used as non-pressurized controls.MICROSCOPIC OBSERVATIONThe morphology of the cells in monolayer culture was observed. SPCs,
BPCs and SFs from the second passage and ACs from the zero passage
were seeded onto a collagen type I-coated 8-well chamber slide (Asahi
Techno Glass, Tokyo, Japan) at a density of 3 103 cells/cm2. After cultur-
ing for 24 h, cell morphology was observed under differential interference
contrast microscopy (Olympus, Tokyo, Japan).CELL PROLIFERATION ANALYSISThe number of cells was evaluated using the CellTiter 96 (Promega)
AQueous One Solution Assay as previously described45. Brieﬂy, SPCs,
BPCs and SFs from the second passage and ACs from the zero passage
were seeded into a 96-well plate at a density of 1000 cells/well in 100 ml of
DMEM; 20 ml of AQueous One Solution was added to each well. After cultur-
ing for various time periods under standard conditions, the absorbance at
490 nm was recorded using an ELISA plate reader. The number of cells
for each cell type, after culturing for 24-, 48- and 72-h, was calculated
compared to the cells at 0-h (1000 cells/well).RNA ISOLATION AND cDNA SYNTHESISThirty minutes after termination of IHP, total RNA was extracted from con-
trol (non-pressurized) cells and IHP-exposed cells in individual plate by using
ISOGEN (Nippon gene, Tokyo, Japan). First strand cDNA was synthesized
using an RNA polymerase chain reaction (PCR) kit (Applied Biosystems,
Foster City, CA, USA), with random hexamers to prime cDNA synthesis as
previously described39.REVERSE TRANSCRIPTASE-PCR (RT-PCR)RT-PCR was performed using the Gene Amp PCR System 9700 (Applied
Biosystems) as previously described46. Speciﬁc primer sets for CD44,
SOX-9, Cbfa-1, GAPDH, and c-Jun were designed based on published
sequence data47e49 as follows: forward primer of 50-AATGGTCGCTATAG
CATCTC-30 and reverse primer of 50-TATGGTAATTGGTCCGTCAA-30 for
CD44; forward primer of 50-TTCATGAAGATGACCGACGA-30 and reverse
primer of 50-CACACCATGAAGGCGTTCAT-30 for SOX-9; forward primer of
50-ACACTGCCACCTCTGACTTCTG-30 and reverse primer of 50-TAGGG
TGGTGGCAGGTAGGTAT-30 for Cbfa-1; forward primer of 50-TCACCA
TCTTCCAGGAGCGA-30 and reverse primer of 50-CACAATGCC for c-Jun.
PCR ampliﬁcation was performed by denaturation at 94C for 30 s, annealing
at 58C for 30 s, and extension at 72C for 60 s. The culture medium of
passage-3 SPCs was replaced by DMEM containing lipopolysaccharide
(LPS) (SigmaeAldrich) at a concentration of 10 mg/ml. After 12 h of culture
with DMEM containing LPS, total RNA was isolated using ISOGEN; this was
considered to be a positive control for mRNA expression of c-Jun50. RT-PCR
products were separated on 1.5% agarose gel containing ethidium bromide
and evaluated for the expression of mRNA for each gene. The band intensity
for each gene was measured using Scion ImageR (Scion Corp., Bethesda,
MD, USA) and standardized to the intensity of GAPDH band.REAL-TIME RT-PCRQuantitative real-time RT-PCR was performed using the Biosystem 7300
sequencer (Applied Biosystems) monitoring the increase of reporter ﬂuores-
cence of each TaqMan probe for proteoglycan core protein (PG), collagen
type II, SOX-9 and collagen type I during PCR. The PCR primers and Taq-
Man probe were designed by Assays-by-DesignSM Service (Applied Biosys-
tems) as: forward primer of 50-CGCCTACCAGGACAAGGT-30, reverse
primer of 50-GCGCAGGCTCTGGATCTC-30 and probe of 50-[FAM]
TCGCTGCCCAACTAC [TAMRA]-30 for PG; forward primer of 50-CCTG
TGCGACGACATAATCTGT-30, reverse primer of 50-GCAGTGGCGAGG
TCAGTAG-30 and probe of 50-[FAM] CAGTCCTTGGTGTCTTC [TAMRA]-
30 for collagen type II; forward primer of 50-GAAGCTCTGGAGACTGCT
GAA-30, reverse primer of 50-CCGCCTCCTCCACGAA-30 and probe of 50-
[FAM] CCGCTTCTCGCTCTCG [TAMRA]-30 for SOX-9; forward primer of
50-GTTCTCAGGGTAGCCAAGGT-30, reverse primer of 50-CTCCATCATAA
CCAAAGTCGTAACCA-30 and probe of 50-[FAM] CCTCCTGGCCCTCCTG
[TAMRA]-30 for collagen type I. In a 25 ml PCR, 1 ml of cDNA (100 ng) was
ampliﬁed using the 50 nM forward and reverse primers, 200 nM Ribosomal
RNA (rRNA) probe (VICeTAMRA labeled) and TaqMan 2 Universal PCR
Master Mix (Applied Biosystems) for the internal control; and 20 mix
primers, TaqMan probe (FAMeTAMRA labeled) and TaqMan 2 Universal
PCR Master Mix for the target genes. Thermal cycling was performed using
40 cycles of 95C for 15 s, followed by 60C for 1 min. For quantiﬁcation of
gene expression, the comparative Ct method was used to calculate the
relative-fold changes normalized against the rRNA51,52. The reported values
are the means of the four samples and each sample was assayed in dupli-
cate. The level of gene expression was calculated as the difference (DCt)
between the Ct value of the sample for the target gene and the mean Ct
value of that sample for the endogenous control (rRNA). The relative
expression was calculated as the difference (DDCt) between the Ct value
of the test sample and that of the control sample. The relative expression
of genes of interest was calculated and expressed as 2DDCt as previously
described53.WESTERN BLOT ANALYSISThirty minutes after termination of IHP, the cells were washed twice with
phosphate buffered saline (PBS), and sonicated in lysis buffer [1% NP-40,
150 mM NaCl, 5 mM EDTA, 50 mM NaF, 20 mM TriseHCl pH 7.5, 2 mM
Na3VO4, 1 mM phenylmethylsulphonylﬂuoride (PMSF) and a protease inhib-
itor cocktail (Nacalai Tesque)] using the Bioruptor (CosmoBio, Tokyo, Japan)
to extract total protein. After centrifugation at 300g for 5 min, the concentra-
tion of the protein was quantiﬁed through the bicinchoninic acid (BCA) assay
using BCA Protein Assay Kit (Pierce, Rockford, IL, USA). The cell extract
containing 10 mg of protein was separated by sodium dodecyl sulfate poly-
acrylamide gel electrophoresis (SDSePAGE) according to the method of
Laemmli54. After transferring to a polyvinylidene diﬂuoride membrane (Hy-
bond-P; Amersham Pharmacia Biotech, Buckinghamshire, UK), SOX-9
and b-actin were detected by incubating the blot with an anti-SOX-9 mono-
clonal antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA)
and an anti-b-actin monoclonal antibody (SigmaeAldrich), respectively, fol-
lowed by incubation with an HRP-labeled anti-rabbit immunoglobulin G
(IgG) antibody (Amersham, Arlington Heights, IL, USA) and an anti-mouse
IgG antibody (Amersham), respectively. The chemiluminescent emission
was detected using an ECL Western blotting detection kit (Amersham) and
the obtained banding patterns were developed on X-ray ﬁlm, as described
previously55. The intensity of each protein band was measured using Scion
ImageR (Scion Corp.) and standardized with the intensity of the b-actin band
in order to evaluate expression levels.
808 K. Sakao et al.: Induction of chondrogenic phenotype in SPCsQUANTITATION OF GLYCOSAMINOGLYCAN (GAG)The alginate beads containing non-pressurized SPCs and IHP-loaded
SPCs were digested in a solubilizing solution (55 mM sodium citrate, 5 mM
EDTA, 0.15 M NaCl, 5 mM cysteine hydrochloride, 0.56 units/ml papain) at
60C for 24 h. After centrifugation at 300g for 3 min, the amount of GAG in
the supernatant was quantiﬁed using the dimethylmethylene blue (DMMB)
assay56. The metachromatic reaction of GAG with DMMB was monitored
with a spectrophotometer, using chondroitin 6 sulfate A (SigmaeAldrich)
as a standard. The total amount of GAG was normalized to the total amount
of protein, as previously described39.STATISTICAL ANALYSISAll values are expressed as the mean  standard deviation (SD). The dif-
ferences in the cell proliferation index among ACs, BPCs, SFs and SPCs
were determined by one-way ANOVA with ad hoc multiple comparison using
Fisher’s least signiﬁcant difference method (LSD) method. The differences in
mRNA expression of PG, collagen type II, SOX-9 and collagen type I among
control, 1.0 MPa and 5.0 MPa IHP-loaded cells were also tested by one-way
ANOVA with ad hoc multiple comparison using Fisher’s LSD method. The
differences in GAG production by SPCs with and without IHP were examined
using the paired t test. The differences in mRNA expression of PG, collagen
type II, and SOX-9 in the no treatment group and three inhibitor pretreatment
groups without IHP were determined by one-way ANOVA with ad hoc multi-
ple comparisons using Fisher’s LSD method. The differences in mRNAA SPCs
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groups, with or without IHP, were determined by using the paired t test, and
the differences in mRNA expression of PG, collagen type II and SOX-9
among the three inhibitor groups were tested by one-way ANOVA with ad
hoc multiple comparisons using Fisher’s LSD method after calculation of
% changes in mRNA expression of cells with IHP compared to that of cells
without IHP in each of the three inhibitor pretreatment groups. Statistical
signiﬁcance was deﬁned as a P-value of less than 0.05.Results
Almost identical results were obtained for all experiments
performed in duplicate or triplicate.IDENTIFICATION OF CELLSAfter 24 h in monolayer culture, the cells were observed
under differential interference contrast microscopy. SPCs,
BPCs and SFs maintained a ﬁbroblastic spindle shape
and there were no remarkable differences in morphology
among them [Fig. 2(A)].
To investigate the cellular characteristics of SPCs, BPCs
and SFs, the mRNA expression of CD44, SOX-9 andBPCs
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809Osteoarthritis and Cartilage Vol. 16, No. 7Cbfa-1, which are expressed in chondrocyte and osteoblast
precursor cells9, was analyzed using RT-PCR. The levels of
mRNA expression of SOX-9 and Cbfa-1 were comparable
in SPCs and BPCs, but were not found in SFs. The
mRNA expression of CD44 was greater in SPCs and
BPCs than in SFs [Fig. 2(B)].
The number of cells of SPCs, BPCs and SFs from the
second passage and ACs from the zero passage was eval-
uated using the CellTiter 96 AQueous One Solution
Assay. After 72 h of culture, the cell number of SPCs,
BPCs, SFs and ACs was 8.7-, 4.3-, 6.2- and 2.1- fold
higher, respectively, than that of uncultured cells. The
number of SPCs after 24-, 48-, and 72-h of culture was
1.4-, 1.6- and 2.0-fold larger than that of BPCs, respectively.
Among SPCs, BPCs, SFs and ACs, SPCs had the highest
expandability [Fig. 2(C)].EFFECT OF IHP ON mRNA EXPRESSION OF PG, COLLAGEN
TYPE II AND SOX-9After exposing the cells to 1.0 or 5.0 MPa of IHP for 1 h,
total RNA was separately extracted from the different cell
types in monolayer culture and analyzed identically by0
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the levels of mRNA expression of PG, collagen type II
and SOX-9 in SPCs after exposure to 5.0 MPa of IHP
increased 1.6-, 1.8- and 1.8-fold, respectively, more than
those in the non-pressurized cells. In SPCs, the expression
of these genes was statistically increased (P< 0.05) follow-
ing exposure to 5.0 MPa of IHP. In BPCs, the expressions
of these genes tended to be increased after exposure to
5.0 MPa of IHP, but this up-regulation showed no signiﬁcant
differences. In SFs, the expression of these genes was not
affected by exposure to either 1.0 or 5.0 MPa of IHP
[Fig. 3(AeC)]. In SPCs, BPCs and SFs, the levels of
mRNA expression of collagen type I, which is a negative
measure of chondrogenic differentiation, showed essen-
tially no change after exposure to either 1.0 or 5.0 MPa of
IHP [Fig. 3(D)].SOX-9 PRODUCTION OF SPCs INDUCED BY IHPAfter exposure to 5.0 MPa of IHP for 1 h, protein was
extracted from SPCs in monolayer culture and analyzed
using Western blot analysis. The expression level of SOX-9
in SPCs was augmented by exposure to IHP (Fig. 4).0
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Fig. 4. Increased production of SOX-9 in SPCs by exposure to IHP.
SPCs in monolayer culture were exposed to 5.0 MPa of IHP for 1 h
or left untreated. ACs not exposed to IHP were used as a positive
control. IHP ; not exposed to IHP, IHP þ; exposed to IHP. Thirty
minutes after the IHP exposure, protein was extracted from cells,
and the cell lysate containing 10 mg of protein was assessed by
Western blot analysis as described in the Materials and methods.
The intensity of each protein band standardized to that of b-actin
in four experiments is shown at the bottom. Values are meanSD.
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Fig. 5. Increased production of GAG in SPCs cultured in alginate
beads by exposure to IHP. SPCs cultured in alginate beads were
exposed to 5.0 MPa of IHP (right) or were non-pressurized (left)
for 1 h. Immediately after the treatment, the beads were removed
from the pressurization apparatus, and cultured in serum-free
DMEM for 4 days. The content of GAG in SPCs was measured
by the DMMB assay as described in the Materials and methods.
Statistically signiﬁcant differences were tested using the paired
t test. *; P < 0.05 vs non-pressurized cells. N ¼ 4, values are
meanSD.
810 K. Sakao et al.: Induction of chondrogenic phenotype in SPCsGAG PRODUCTION BY SPCs CULTURED IN ALGINATE BEADS
INDUCED BY IHPThe GAG content of SPCs cultured in alginate beads was
evaluated using theDMMBassay. After exposure to 5.0 MPa
of IHP for 1 h, SPCs in alginate beadswere cultured in serum-
free DMEM for 4 days. The GAG content was 14.7 0.9 ng/
bead in non-pressurized cells and 17.7 0.5 ng/bead in IHP-
loaded cells, a 1.2-fold increase. The content of GAG in IHP-
loaded cells was statistically increased compared to that in
the non-pressurized cells (P< 0.05) (Fig. 5).EFFECT OF MAP KINASE INHIBITION ON IHP-INDUCED
EXPRESSION OF CHONDROCYTE-SPECIFIC GENES IN SPCsNo signiﬁcant differences were found in mRNA expres-
sion of PG, collagen type II or SOX-9 among the untreated
cells, or cells pretreated with JNK, ERK or p38 inhibitors.
The mRNA expression of PG was 1.00 0.11-fold in un-
treated cells (control), 0.99 0.17-fold in cells pretreated
with JNK inhibitor, 0.98 0.12-fold in cells pretreated with
ERK inhibitor, 0.92 0.11-fold in cells pretreated with p38
inhibitor. The mRNA expression of collagen type II was
1.00 0.38-fold in untreated cells (control), 0.84 0.10-
fold in cells pretreated with JNK inhibitor, 0.75 0.08-fold
in cells pretreated with ERK inhibitor and 1.06 0.09-fold
in cells pretreated with p38 inhibitor. The mRNA expression
of SOX-9 was 1.00 0.19-fold in untreated cells (control),
0.89 0.13-fold in cells pretreated with JNK inhibitor,
1.04 0.19-fold in cells pretreated with ERK inhibitor, and
0.72 0.18-fold in cells pretreated with p38 inhibitor.
MAP kinase inhibitors for JNK, ERK or p38 pathways
were used to investigate whether the mRNA up-regulation
of chondrocyte-speciﬁc genes, including PG, collagen
type II and SOX-9 was mediated by MAP kinase pathways.
The cells were pretreated with the indicated MAP kinasepathway inhibitors for 2 h in monolayer culture. The cells
were subsequently exposed to 5.0 MPa of IHP for 1 h, or
left untreated as non-pressurized controls. After culture for
30 min, total RNA was extracted and subjected to real-
time RT-PCR analysis using primers/probes speciﬁc for
PG, collagen type II and SOX-9. When cells were subjected
to 5.0 MPa of IHP, the mRNA expression of PG, collagen
type II and SOX-9 statistically increased (P< 0.05)
[Fig. 3(AeC)]. This increase was suppressed only by
pretreatment of the cells with the JNK inhibitor, but not by
ERK or p38 inhibitors [Fig. 6(A,C and E)]. A signiﬁcant
suppressive effect on the expression of these genes
increased by IHP loading was observed only with the JNK
inhibitor, compared to the ERK inhibitor and p38 inhibitor
[Fig. 6(B, D and F)].
To examine whether the induction of mRNA expression
of PG, collagen type II and SOX-9 was mediated by the
expression of c-Jun, the mRNA expression of c-Jun was
analyzed by RT-PCR in SPCs in monolayer culture.
Compared to untreated cells, no difference in mRNA
expression of c-Jun was observed in cells that had been
pretreated with the JNK inhibitor, but not subjected to IHP.
IHP increased the mRNA expression of c-Jun, but this
increase was completely suppressed by pretreatment of
the cells with the JNK inhibitor [Fig. 7(A)].
To determine whether IHP-induced production of SOX-9
was by the MAP kinase/JNK pathway in SPCs in monolayer
culture, the expression of SOX-9 was analyzed using West-
ern blot analysis. Compared to untreated cells, no differ-
ence in the expression of SOX-9 protein was observed in
cells that had been pretreated with JNK inhibitor, but not
subjected to IHP. IHP also increased the expression of
SOX-9 protein, but this increase was suppressed by pre-
treating cells with the JNK inhibitor [Fig. 7(B)].
Discussion
The effects of mechanical stress on chondrocytes have
been reported by several researchers. Cyclic tensile force
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Fig. 6. An inhibitor of JNK suppressed the IHP-induced mRNA expression of PG, collagen type II and SOX-9 in SPCs. SPCs in monolayer
culture were pretreated with the indicated MAP kinase pathway inhibitors as described in the Materials and methods. The cells were subse-
quently exposed to 5.0 MPa of IHP for 1 h, or left untreated as non-pressurized controls. IHP ; not exposed to IHP, IHP þ; exposed to IHP.
After further culture for 30 min, total RNA was extracted and subjected to real-time RT-PCR analysis using primers/probes speciﬁc for PG,
collagen type II and SOX-9. Statistically signiﬁcant differences among non-pressurized controls (no treatment, pretreated with JNK inhibitor,
pretreated with ERK inhibitor and pretreated with p38 inhibitor) were evaluated using one-way ANOVA. Statistically signiﬁcant differences be-
tween groups (pressurized and non-pressurized) were determined using the paired t test (A, C and E). #; P< 0.05 vs non-pressurized control.
N¼ 4, values are meanSD. Statistically signiﬁcant differences among the three inhibitor groups were investigated by one-way ANOVA after
calculation of % changes in mRNA expression of cells with IHP compared to that of cells without IHP in each of the three inhibitor pretreatment
groups (B, D and F). *; P< 0.05 vs pretreated with the JNK inhibitor. N¼ 4, values are meanSD.
811Osteoarthritis and Cartilage Vol. 16, No. 7(9% elongation) enhanced the expression of terminal differ-
entiation hypertrophic markers in chondrocytes57. Shearing
force levels of 0.2e1.6 Pa exposed to chondrocytes reduced
matrix synthesis58. In contrast, cyclic compressive force
ranging from 3 to 10% strain increased chondrocyte-speciﬁc
matrix synthesis59,60. Hydrostatic pressure has been investi-
gated extensively and reported to have profound effects on
matrix synthesis and phenotype of chondrocytes25,26,61,62.We previously used human chondrocyte-like cells to show
that matrix synthesis could be accelerated by applying phys-
iological pressure generated by continuous hydrostatic pres-
sure (1.0e5.0 MPa)63. It has also been reported that applying
IHP of 5.0 MPa to chondrocytes induced mRNA expressions
of aggrecan and collagen type II24,27,28. Furthermore, the
application of IHP to BPCs has recently been reported to
increase the production of aggrecan and collagen type II64.
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Fig. 7. An inhibitor of JNK suppressed IHP-induced c-Jun and SOX-9 expression in SPCs. SPCs in monolayer culture were pretreated with
a JNK pathway inhibitor for 2 h, or left untreated as described in the Materials and methods. JNK inhibitor ; not pretreated with a JNK path-
way inhibitor, JNK inhibitor þ; pretreated with a JNK pathway inhibitor. The cells were subsequently exposed to 5.0 MPa of IHP for 1 h, or left
untreated as non-pressurized cells. IHP ; not exposed to IHP, IHP þ; exposed to IHP. mRNA expression of c-Jun (A). Thirty minutes after
termination of IHP, the total RNA was extracted and subjected to RT-PCR analysis using primers/probes speciﬁc for c-Jun. LPS-stimulated
SPCs were regarded as a positive control (PC) for the expression of c-Jun. Lane 1, untreated SPCs; lane 2, IHP-loaded SPCs but not pre-
treated with JNK inhibitor; lane 3, IHP-loaded SPCs pretreated with JNK inhibitor; lane 4, SPCs pretreated with JNK inhibitor but not exposed
to IHP; lane 5, LPS-stimulated SPCs (PC). The intensity of each gene band standardized to that of GAPDH in four experiments is shown at the
bottom. Values are meanSD. Expression of SOX-9 (B). Thirty minutes after termination of IHP, the total protein was extracted and a cell
extract containing 10 mg of protein was subjected to Western blot analysis for SOX-9. Lane 1, ACs not exposed to IHP; lane 2, untreated
SPCs; lane 3, SPCs pretreated with JNK inhibitor but not exposed to IHP; lane 4, IHP-loaded SPCs not pretreated with JNK inhibitor; lane
5, IHP-loaded SPCs pretreated with JNK inhibitor. The intensity of each protein band standardized to that of b-actin in three experiments
is shown at the bottom. Values are meanSD.
812 K. Sakao et al.: Induction of chondrogenic phenotype in SPCsThese ﬁndings suggest that hydrostatic pressure not only
enhances the chondrogenic phenotype, but also facilitates
differentiation of progenitor cells into chondrocytes. There-
fore we chose IHP as the mechanical stress to be applied
in this study. Physiological loading of the articular cartilage
was simulated using a newly designed IHP apparatus deliv-
ering the conditions of magnitude; 5.0 MPa, frequency;
0.5 Hz, for a duration of 1 h. While walking, 3e10 MPa of
pressure is reportedly applied to the human hip joint65. For
this study we selected 5.0 MPa because the application of
IHP at this physiological pressure has been reported to
increase cartilage matrix metabolism24,27,28. A frequency of
0.5 Hz was selected because, when weight-bearing walking
was simulated in postoperative rehabilitation, a walking
velocity of about 4 km/h equated to about 0.5 Hz66. Because
previous studies have shown that a few hours of IHP
increases cartilage matrix metabolism24,27,28, we chose to
apply IHP for 1 h.
The present study demonstrated that physiological hydro-
static pressure (5.0 MPa) applied to SPCs in vitro signiﬁ-
cantly increased expressions of mRNA for PG, collagen
type II and SOX-9, which are chondrocyte-speciﬁc genes.
The IHP-induced differentiation of SPCs into chondrocytes
was greater than that of BPCs and SFs. Furthermore,
when IHP was applied to SPCs, the production of SOX-9
protein was elevated and the production of GAG, an impor-
tant component of the cartilage matrix, was increased. The
Sry-related gene SOX-9 is expressed during chondrogene-
sis in mesenchymal progenitor cells67,68. SOX-9 controls
cartilage differentiation and plays an important role as a tran-
scription factor for PG and collagen type II69e71; this
suggests that SOX-9 induction by IHP accelerates the
expression of PG and collagen type II. OA is a disease pre-
dominantly characterized by articular cartilage degenerationreportedly occurring in weight-bearing areas72. Damage to
cartilage is of more clinical signiﬁcance when it occurs in
weight-bearing areas. When performing progenitor cell
transplantation as a new cellular treatment for OA or dam-
aged cartilage, the effects of postoperative joint movements
and loading in applying mechanical stress to the treated
area are of importance. The present study conﬁrms the
induction of cartilage differentiation by IHP in vitro and pro-
vides valuable clues for applying appropriate mechanical
stress during postoperative rehabilitation and for developing
a new method of cartilage regeneration that actively
induced cartilage differentiation.
The cell proliferation ability of SPCs is greater than that of
BPCs or SFs17. Because SPCs are easily harvested and
proliferated and can be differentiated into chondrocytes by
the application of mechanical stress, SPCs appear to be
a suitable cell source for regenerative medicine in the treat-
ment of extensive cartilage damage or in OA. Furthermore,
because sufﬁcient synovium is easily harvested from OA
joints, SPCs may be useful as a cell source for regenerative
medicine using the preferred autologous tissue grafts
instead of allografts.
The induction mechanism of cartilage differentiation from
progenitor cells by mechanical stress has not been fully
elucidated. The precise mechanism by which IHP loading
stimulated cells remains unknown, some possible mecha-
nisms have been reported. The present study showed
that an inhibitor of JNK, an MAP kinase involved with major
intracellular signal transduction, signiﬁcantly suppressed
mRNA expressions of PG, collagen type II and SOX-9 in-
duced by IHP. One recent study shows that the application
of intermittent compressive force to BPCs induced the
expression of SOX-9, the transcription factor for the induc-
tion of cartilage differentiation, by the expression of c-Jun,
813Osteoarthritis and Cartilage Vol. 16, No. 7one of the activated proteins49. In the present study, the
suppression of the JNK pathway controlled the mRNA
expression of c-Jun induced by IHP. At the protein level, in-
creased SOX-9 production by IHP could also be controlled
by suppressing the JNK pathway. These ﬁndings suggest
that IHP-induced cartilage differentiation by SPCs may be
mediated by the JNK pathway. A previous study of vascular
endothelial cells showed that the JNK pathway is involved
in signal transduction for IHP and in increased expression
of c-Jun73. The present study is the ﬁrst to report mecha-
nisms for cartilage differentiation via increased expressions
of c-Jun and SOX-9 by SPCs after exposure to IHP.
Several studies have been conducted to induce the differ-
entiation of SPCs into chondrocytes using growth factors,
such as TGF-b1 and BMP-274 or gene induction such as
the Smad pathway75. It has been also reported that
mechanical stress applied to BPCs induces cartilage differ-
entiation49,64. To the best of our knowledge, no previous
studies have applied mechanical stress to SPCs and inves-
tigated cartilage differentiation. The results of our study sug-
gest the possibility that the repair process of cartilage
tissues using SPCs in joints might be facilitated with the
application of mechanical stress. Appropriate rehabilitation
should accelerate cartilage differentiation by the MAP
kinase/JNK pathway. Some growth factors, such as TGF-b
and IGF-I, have been reported to have synergistic effects
with mechanical stress on cartilage regeneration76,77. These
factors could be examined to use in the rehabilitation pro-
grams. Furthermore, our study suggests the possibility of in-
cubating SPCs in an IHP device as a bioreactor to stimulate
differentiation of SPCs into chondrocytes, which could then
be utilized for cell therapy for the cartilage tissue. This could
lead to the development of regenerative treatments for car-
tilage tissues that have been difﬁcult to regenerate.Conﬂict of interest
Each author certiﬁes that there were no ﬁnancial or per-
sonal relationships with other people or organization that
could inappropriately inﬂuence this work.References
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